Washington University School of Medicine and the Division of Nephrology announces a scientific symposium in honor of the career of Eduardo Slatopolsky, MD. This event will takes place on April 8, 2016, in the Eric P. Newman Conference Center. CME credit is available. The registration fee is complimentary, but registration is required.
1) Accurately diagnose and evaluate patients with chronic kidney disease.
2) Appropriately manage renal osteodystrophy in chronic kidney disease.
3) Recognize the physiology of PTH secretion in health and in chronic kidney disease.
4)Identify mechanisms of chronic kidney disease and its implications for developing new therapeutic approaches.
5) Recognize the increasing role that FGF23 plays in identifying patients at risk of renal osteodystropy.
|9:00||Vicky Fraser, Washington University|
|9:05||Ben Humphreys, Washington University|
|Session I.||Mineral Metabolism|
Kevin J Martin, St. Louis University
Pathogenesis of Secondary Hyperparathyroidism: 50 Years of Progress
Justin Silver, Hadassah Hebrew University Medical Center
Mechanisms of PTH Secretion in Health and Disease
Klaus Olgaard, University of Copenhagen
Evolution of Treatments for Secondary Hyperparathyroidism
Steve Teitelbaum, Washington University
The Osteoclast; what does it do and how does it do it?
Ravi Thadhani, Harvard University
Vitamin D, ESRD and Survival
||Pathogenesis of Progression
Joseph V. Bonventre, Harvard University
Role of Epithelium in CKD Progression
Benjamin Humphreys, Washington University
Mechanisms of Myofibroblast activation and Interstitial Fibrosis
James A. Shayman, University of Michigan
Targeting glycosphingolipid metabolism in the treatment of rare and common renal diseases
Michael Goligorsky, New York Medical College
The Endothelium in Health and Chronic Kidney Disease
Myles Wolf, Northwestern University
Clinical Aspects of FGF23 in Kidney and Heart
Orson Moe, University of Texas Southwestern
Biology of Klotho and FGF23